Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
General Thoracic and Cardiovascular Surgery|March 28, 2012
Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failureTomohito Sadahiro, Shigeto Oda, Masataka Nakamura, et al.
Shock (Augusta, Ga.)|December 14, 2007
Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patientsYoshihisa Tateishi, Shigeto Oda, Masataka Nakamura, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 23, 2008
Continuous hemodiafiltration in the treatment of reactive hemophagocytic syndrome refractory to medical therapyYoshihisa Tateishi, Shigeto Oda, Tomohito Sadahiro, et al.
Contributions to Nephrology|May 18, 2010
Non-renal indications for continuous renal replacement therapy: current status in JapanShigeto Oda, Tomohito Sadahiro, Yo Hirayama, et al.
Blood Purification|December 8, 2010
Comparison of interleukin-6 removal properties among hemofilters consisting of varying membrane materials and surface areas: an in vitro studyYo Hirayama, Shigeto Oda, Kiyohito Wakabayashi, et al.
Cytokine|July 4, 2012
Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patientsEizo Watanabe, Barbara A Zehnbauer, Shigeto Oda, et al.
Critical Care Medicine|October 16, 2004
Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury modelYoh Hirayama, Hiroyuki Hirasawa, Shigeto Oda, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 26, 2008
The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF)Masataka Nakamura, Shigeto Oda, Tomohoto Sadahiro, et al.
Journal of the Neurological Sciences|November 11, 2003
Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosisShoichi Ito, Satoshi Kuwabara, Ryuji Sakakibara, et al.
International Immunopharmacology|September 20, 2011
Experimental examination of anti-inflammatory effects of a 5-HT3 receptor antagonist, tropisetron, and concomitant effects on autonomic nervous function in a rat sepsis modelDaisuke Setoguchi, Masataka Nakamura, Henry Yatsuki, et al.
Pageof 19